Therapeutics: Toll-like receptor 9 (TLR9)

Endocrine/metabolic disease

INDICATION: Diabetes

Patient sample and mouse studies suggest TLR9 antagonists could help treat insulin

Read the full 148 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE